Distek partners with Optimal Biotech Group to expand BIOne Bioreactor Solutions on the West Coast
Optimal Biotech Group will represent Distek’s BIOne portfolio, including the BIOne 250 and BIOne 1250 Bioreactor Controllers, as well as BIOne Single-Use Bioreactors and Fermentors
14 Apr 2026
Distek partners with Optimal Biotech to expand BIOne Bioreactor Solutions on the West Coast
Distek, Inc., a provider of pharmaceutical and bioprocessing instrumentation, has announced an exclusive manufacturers’ representative agreement with Optimal Biotech Group, LLC to support its BIOne benchtop bioreactor solutions across California, Oregon, and Washington.
Through this agreement, Optimal Biotech Group will represent Distek’s BIOne portfolio, including the BIOne 250 and BIOne 1250 Bioreactor Controllers, as well as BIOne Single-Use Bioreactors and Fermentors. This expanded regional representation strengthens Distek’s ability to support biopharmaceutical and biotechnology organizations with flexible, scalable solutions for upstream process development and manufacturing.
This partnership reinforces Distek’s commitment to advancing its BIOne platform and providing customers with innovative, high-quality solutions supported by knowledgeable regional expertise. By strengthening its presence in critical biotechnology hubs, Distek continues to invest in accessibility, service, and long-term customer success.
“Expanding our existing BIOne footprint in California, Oregon, and Washington is a strategic step in ensuring we deliver strong, localized support in key biopharma markets,” said Jeff Seely, Vice President of Sales & Business Development at Distek. “Optimal Biotech Group’s technical expertise and established presence in these states make them an excellent partner to represent our growing bioprocessing portfolio.”

